Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pulmatrix Inc (PULM)

Pulmatrix Inc (PULM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,865
  • Shares Outstanding, K 19,625
  • Annual Sales, $ 150 K
  • Annual Income, $ -20,560 K
  • 60-Month Beta 1.29
  • Price/Sales 90.43
  • Price/Cash Flow N/A
  • Price/Book 0.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.67
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -1.00
  • Growth Rate Est. (year over year) +66.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.70 +0.93%
on 10/17/19
0.88 -19.55%
on 09/20/19
-0.15 (-17.48%)
since 09/18/19
3-Month
0.70 +0.93%
on 10/17/19
1.03 -31.41%
on 08/23/19
-0.20 (-22.28%)
since 07/18/19
52-Week
0.70 +0.93%
on 10/17/19
4.60 -84.64%
on 11/21/18
-2.79 (-79.81%)
since 10/18/18

Most Recent Stories

More News
Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmonary Aspergillosis in Patients with Asthma

Pulmatrix, Inc. (NASDAQ: PULM) today announced that the first patient has been dosed in the Phase 2 trial evaluating Pulmazole, an inhaled iSPERSE formulation of the antifungal itraconazole in development...

PULM : 0.71 (unch)
Pulmatrix Receives US Patent Covering iSPERSE(TM) Formulations for Pulmazole Program

Pulmatrix, Inc. (NASDAQ: PULM) has received a grant from the United States Patent and Trademark Office for US Pat. No. 10376465. Granted claims cover iSPERSE formulations of the company's lead pipeline...

PULM : 0.71 (unch)
Pulmatrix Reports Q2 2019 Results

Pulmatrix, Inc. (NASDAQ: PULM) today reports its second quarter results.

PULM : 0.71 (unch)
Pulmatrix Activates Sites for Pulmazole Phase 2 Clinical Study

Pulmatrix, Inc. (NASDAQ: PULM) announces today that three sites in the United States have been activated for the Phase 2 clinical investigation for Pulmazole (PUR1900) - an inhaled iSPERSETM formulation...

PULM : 0.71 (unch)
Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix

Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix

HPQ : 16.85 (-0.65%)
ABBV : 76.46 (+1.76%)
ONCS : 2.24 (+5.66%)
PULM : 0.71 (unch)
PRTY : 6.60 (+1.38%)
Bet on 5 Top Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E to realize outsized gains.

HPQ : 16.85 (-0.65%)
ABBV : 76.46 (+1.76%)
ONCS : 2.24 (+5.66%)
PULM : 0.71 (unch)
PRTY : 6.60 (+1.38%)
Pulmatrix Announces Leadership Change

Pulmatrix, Inc. (NASDAQ: PULM) announces today that Dr. Robert Clarke has stepped down as Chief Executive Officer. Ted Raad will immediately transition from his current role as Chief Business Officer...

PULM : 0.71 (unch)
Pulmatrix Reports Q1 2019 Results

Pulmatrix, Inc. (NASDAQ: PULM) today reports its first quarter results.

PULM : 0.71 (unch)
Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole(TM)

Pulmatrix, Inc. (NASDAQ: PULM; hereafter referred to as "Pulmatrix"), a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease,...

PULM : 0.71 (unch)
Pulmatrix, Inc. Announces Closing of $16.6 Million Upsized Public Offering

Pulmatrix, Inc. ("Pulmatrix," the "Company," "we," "our" or "us") (NASDAQ: PULM) today announced the closing of its previously announced underwritten public offering of an aggregate of 1,719,554 common...

PULM : 0.71 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade PULM with:

Business Summary

Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease...

See More

Key Turning Points

2nd Resistance Point 0.72
1st Resistance Point 0.71
Last Price 0.71
1st Support Level 0.70
2nd Support Level 0.70

See More

52-Week High 4.60
Fibonacci 61.8% 3.11
Fibonacci 50% 2.65
Fibonacci 38.2% 2.19
Last Price 0.71
52-Week Low 0.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar